NeuroTrials.ai The Neurology Trials Database
About Contact
Trials Latest Wiki Journal Evidence
AI-Powered Neurology Evidence Search

Other Trials

August 2026 · 4 Trials · NeuroTrials.ai
FEATURED THIS WEEK
Does adjunct dexamethasone improve verbal memory outcomes in adults with herpes simplex virus encephalitis treated with aciclovir?

DexEnceph

Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial

Lancet Neurology · 2026

Bottom Line: Adding dexamethasone to standard aciclovir treatment did not improve verbal memory at 26 weeks in adults with HSV encephalitis. The trial was safe with no evidence of harm from dexamethasone and no increase in viral persistence. Routine use of adjunct dexamethasone in HSV encephalitis is not supported; however, a post-hoc…

CHRONIC KIDNEY DISEASE 1

Does low-dose rivaroxaban (2.5 mg twice daily) reduce major adverse cardiovascular events compared with placebo in patients with advanced chronic kidney disease?

TRACK

2026

NORMAL PRESSURE HYDROCEPHALUS 1

Does low-dose acetazolamide improve gait function compared with placebo in patients with idiopathic normal pressure hydrocephalus awaiting shunt surgery?

DRAIN

2026

TRAUMATIC BRAIN INJURY 1

In patients with large acute epidural haematoma and tentorial herniation, does primary decompressive craniectomy improve 6-month functional outcomes compared with standard craniotomy with bone-flap replacement?

PREDICT-AEDH

2026

ENCEPHALITIS (HSV) 1

Does adjunct dexamethasone improve verbal memory outcomes in adults with herpes simplex virus encephalitis treated with aciclovir?

DexEnceph

2026